Status:

COMPLETED

Akkermansia and Weight Maintenance

Lead Sponsor:

Maastricht University Medical Center

Conditions:

Obesity

Microtia

Eligibility:

All Genders

20-70 years

Phase:

NA

Brief Summary

Obesity and related disorders such as type 2 diabetes are a worldwide diet-related problem. As such new treatment options are constantly being developed. Bacteria living in the gut seem to be a key pl...

Detailed Description

RATIONALE This study will examine the influence of specific beneficial gut bacteria in relation to weight maintenance. The worldwide prevalence of obesity, obesity-associated insulin resistance, and t...

Eligibility Criteria

Inclusion

  • BMI ≥ 28 kg/m2 \< 40 kg/m2
  • Weight stable for at least 3 months (± 2 kg).

Exclusion

  • Type 2 diabetes mellitus (fasting plasma glucose ≥ 7.0 mmol/L)
  • Gastroenterological diseases
  • Surgery on the gastrointestinal tract (ex.Bariatric surgery)
  • Cardiovascular diseases, cancer, liver or kidney malfunction, a disease with a life expectancy of \< 5 years;
  • Alcohol (\>15 standard drinks per week) or drug abuse
  • Excessive nicotine use is defined as \>20 cigarettes per day;
  • Use of prebiotics or probiotics 3 months prior to the start of the study;
  • Intensive exercise training, \> 3 hours a week;
  • Use of any medication influencing glucose or fat metabolism (ex. lipid-lowering-drugs e.g. PPAR γ (peroxisome proliferator-activated receptors) or PPARα (fibrates) agonists), glucose-lowering agents (including all sulfonylureas, biguanides, α-glucosidase inhibitors, thiazolidinediones, repaglinide, nateglinide, and insulin), inflammation (e.g. anti-inflammatory or immunosuppressive drugs) and anti-oxidants);
  • Regular use of laxatives
  • Use of antibiotics in the last 3 months
  • Vegan
  • Lactose intolerance
  • Pregnancy or lactation
  • Concomitant participation in another study

Key Trial Info

Start Date :

July 22 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 20 2023

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT05417360

Start Date

July 22 2022

End Date

November 20 2023

Last Update

November 27 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Human Biology, Maastricht University Medical Centre

Maastricht, Limburg, Netherlands, 6200MD

Akkermansia and Weight Maintenance | DecenTrialz